Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,593 | 468 | 98.2% |
| Education | $155.79 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,524 | 74 | $0 (2024) |
| ABBVIE INC. | $1,424 | 140 | $0 (2024) |
| ITI, Inc. | $1,373 | 43 | $0 (2023) |
| Alkermes, Inc. | $1,202 | 51 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $943.96 | 47 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $640.55 | 29 | $0 (2024) |
| Axsome Therapeutics, Inc. | $365.15 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $334.04 | 18 | $0 (2022) |
| Lundbeck LLC | $204.37 | 13 | $0 (2024) |
| Tris Pharma Inc | $183.89 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,669 | 78 | ABBVIE INC. ($353.58) |
| 2023 | $1,634 | 96 | ITI, Inc. ($259.01) |
| 2022 | $3,051 | 143 | Teva Pharmaceuticals USA, Inc. ($635.05) |
| 2021 | $2,394 | 154 | ITI, Inc. ($497.83) |
All Payment Transactions
471 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: CNS | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.31 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: CNS | ||||||
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $101.49 | General |
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: CNS | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: CNS | ||||||
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Neuropsychiatry | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $114.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 26 | 141 | $28,810 | $10,991 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 12 | 100 | $21,380 | $8,218 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 41 | $7,430 | $2,773 | 37.3% |
About Alicja Matusiak, LISW-S, CNP
Alicja Matusiak, LISW-S, CNP is a Clinical healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2009. The National Provider Identifier (NPI) number assigned to this provider is 1174757678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alicja Matusiak, LISW-S, CNP has received a total of $8,749 in payments from pharmaceutical and medical device companies, with $1,669 received in 2024. These payments were reported across 471 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($8,593).
As a Medicare-enrolled provider, Matusiak has provided services to 26 Medicare beneficiaries, totaling 141 services with total Medicare billing of $10,991. Data is available for 1 year (2022–2022), covering 2 distinct procedure/service records.
Practice Information
- Specialty Clinical
- Other Specialties Home Health, Psychiatric/Mental Health
- Location Columbus, OH
- Active Since 05/12/2009
- Last Updated 04/08/2025
- Taxonomy Code 1041C0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174757678
Products in Payments
- CAPLYTA (Drug) $1,451
- VRAYLAR (Drug) $1,424
- AUSTEDO (Drug) $1,041
- REXULTI (Drug) $957.48
- ARISTADA (Drug) $689.72
- INGREZZA (Drug) $640.55
- LYBALVI (Drug) $456.11
- Auvelity (Drug) $365.15
- LATUDA (Drug) $334.04
- Austedo XR (Drug) $198.19
- Dyanavel XR (Drug) $183.89
- UZEDY (Drug) $183.09
- INVEGA SUSTENNA (Drug) $122.55
- ABILIFY MAINTENA (Drug) $121.70
- TRINTELLIX (Drug) $115.67
- SECUADO (Drug) $69.23
- ABILIFY ASIMTUFII (Drug) $69.15
- HETLIOZ (Drug) $60.75
- SPRAVATO (Drug) $45.31
- VIVITROL (Drug) $28.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.